Muse cells, stem cell secretomes, exosomes
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Assess short-term and long-term outcomes of Dezawa MuseCells used to treat various diseases as part of regular medical care.
Observational clinical outcomes registry collecting online survey data on symptoms and clinical outcomes for 5 years from participants treated with Dezawa MuseCells.
ClinicalTrials.gov registry record published on 2026-07-01.
License and apply naturally occurring, ethically sourced, non-tumorigenic, immune-tolerant Muse cells for regenerative medicine, longevity, orthopedics, aesthetics, military and sports medicine, and related applications requiring immune compatibility and IV delivery without reprogramming or immunosuppression.
Cell-therapy platform based on Dezawa MuseCells.
Platform described on company site as available for licensing across multiple regenerative and longevity-related applications.
License Muse-cell-derived exosome technology for regenerative medicine, longevity, aesthetics, orthopedics, and related applications.
Exosome-based regenerative medicine platform associated with Dezawa MuseCells.
Listed by the company as part of its licensed technology platform.
License Muse-cell-derived secretome technology for regenerative medicine, longevity, aesthetics, orthopedics, and related applications.
Secretome-based regenerative medicine platform associated with Dezawa MuseCells.
Listed by the company as part of its licensed technology platform.
Investigate why Muse stem cells show enduring stress capacity.
Comparative proteome analysis of Muse stem cells.
Publication listed on the company research hub and PubMed.